Elanco Animal Health (ELAN) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Total Revenue Chart for Elanco Animal Health

Elanco Animal Health (ELAN) revenue for FY2025 was USD 4.7B, a 6.2% change from FY2024. Elanco Animal Health's revenue grew from USD 2.9B in 2015 to USD 4.7B in 2025 (62.1% over 10 years). Earnings per share moved from USD -0.59 in 2015 to USD -0.16 in 2022. Revenue compound annual growth rate: 5-year CAGR of 7.6%, 10-year CAGR of 4.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$11.17B
Implied Share Price
$22.36
Enterprise Value
$14.66B
Revenue (TTM)
$5.02B
EBITDA
$1.01B
Profit Margin
-3.96%
Trailing P/E
—
Forward P/E
17.36
Price/Book (MRQ)
1.71
Price/Sales (TTM)
2.23
EV/EBITDA
18.92
EV/Revenue
2.92
Dividend Yield
—
Book Value
$13.19
Free Cash Flow (FY2025)
$284.00M
Free Cash Flow Yield
2.54%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.